Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.30
BATS BZX Real-Time Price
As of 10:34am ET
 +0.01 / +0.44%
Today’s Change
1.93
Today|||52-Week Range
3.84
+8.49%
Year-to-Date

Today’s Trading

Previous close2.29
Today’s open2.30
Day’s range2.27 - 2.31
Volume15,597
Average volume (3 months)2,293,052
Market cap$379.1M
Dividend yield--
Data as of 10:34am ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-73.25%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+1.85%
P/E ratio2.2
Price/Sales0.97
Price/Book0.53

Competitors

 Today’s
change
Today’s
% change
MRUSMerus NV0.000.00%
XBITXBiotech Inc-0.04-0.31%
ATRAAtara Biotherapeutic...+0.20+1.48%
NVAXNovavax Inc-0.02-1.11%
Data as of 10:31am ET, 01/24/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)$0.09
Annual revenue (last year)$595.8M
Annual profit (last year)$332.8M
Net profit margin55.85%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts


Search for Jobs